Research Output per year
Personal profile
Public Profile
Dr Shanmuganathan is a clinical and laboratory haematologist, conducting her PhD in leukaemia genomics. Not only is she a clinical research fellow at SAHMRI but she continues to consolidate her clinical experience as the Leukaemia Fellow at the Royal Adelaide Hospital. She is currently a recipient of the Dawes scholarship from the Royal Adelaide Hospital.
Education/Academic qualification
Fellowship of the Royal Australasian College of Physicians
Fellowship of the Royal College of Pathologists of Australia
Bachelor's Degree, University of Adelaide
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2011 2019
Bone marrow fibrosis associated with long-term imatinib therapy: Resolution after switching to a second-generation TKI
Shanmuganathan, N., Branford, S., Hughes, T. & Hiwase, D., 12 Feb 2019, In : Blood Advances. 3, 3, p. 370-374 5 p.Research output: Contribution to journal › Article
1
Citation
(Scopus)
Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission
Shanmuganathan, N., Braley, J. A., Yong, A., Hiwase, D., Yeung, D., Ross, D., Hughes, T. & Branford, S., 4 Jul 2019, In : Blood. 134, 1, p. 85-89 5 p.Research output: Contribution to journal › Letter
11
Citations
(Scopus)
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease
Branford, S., Wang, P., Yeung, D., Thomson, D., Purins, A., Wadham, C., Shahrin, N. H., Marum, J. E., Nataren, N., Parker, W. T., Geoghegan, J., Feng, J., Shanmuganathan, N., Mueller, M. C., Dietz, C., Stangl, D., Donaldson, Z., Altamura, H., Georgievski, J., Braley, J. & 13 others, 30 Aug 2018, In : Blood. 132, 9, p. 948-961 14 p.Research output: Contribution to journal › Article
1
Citation
(Scopus)
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells
on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG), 1 Dec 2018, In : Leukemia. 32, 12, p. 2572-2579 8 p.Research output: Contribution to journal › Article
Molecular monitoring in CML: How deep? How often? How should it influence therapy?
Shanmuganathan, N. & Hughes, T., 30 Nov 2018, In : Hematology. 2018, 1, p. 168-176 9 p.Research output: Contribution to journal › Article